FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386987688> ?p ?o ?g. }

• W4386987688 endingPage "S123" @default.
• W4386987688 startingPage "S123" @default.
• W4386987688 abstract "There is no one-size-fits-all treatment decision for non-melanoma skin cancer (NMSC) in elderly patients, especially patients over 80 years old with multiple comorbidities. As a minimally invasive technology, iodine-125 seeds interstitial brachytherapy (BT) has been applied to solid tumors of the whole body, because it can offer a better dose distribution, which considered to be an effective, simple and safe alternative for local treatment of cancer. We aimed to explore its safety and efficacy for age 80 or older patient with early primary high-risk NMSC. As a retrospective and monocentric report, we collected 80+ year-old patients with early primary high-risk non-melanoma skin cancer treated by personalized iodine-125 seeds interstitial brachytherapy (PISI-BT) between December 2003 and May 2020. Survival status, efficacy, adverse effects (AEs), cosmetic result, cost were recorded (data cut-off, November 20st 2021). Results Only 9 patients met the criteria, median age was 86 (81-90), 5 of 9 were Eastern Cooperative Oncology Group (ECOG) 1, and each of them suffered from at least one comorbidity. After a median follow-up of 29.3 months (3-99), only 2 patients alive, 6 patients showed complete response (CR), 3 showed partial response(PR), and stable disease(SD), progressive disease(PD) were 0, respectively. No recurrences, disease persistence and AEs were detected during the follow-up and the death causes was irrelevant to NMSC. The cosmetic result of Excellent and Good were 2 and 4, 3 cannot be evaluated. The cost (included in the scope of medical insurance reimbursement) was acceptable. Conclusions PISI-BT could be an alternative in 80+ year-old patients with early primary high-risk NMSC. There is no one-size-fits-all treatment decision for non-melanoma skin cancer (NMSC) in elderly patients, especially patients over 80 years old with multiple comorbidities. As a minimally invasive technology, iodine-125 seeds interstitial brachytherapy (BT) has been applied to solid tumors of the whole body, because it can offer a better dose distribution, which considered to be an effective, simple and safe alternative for local treatment of cancer. We aimed to explore its safety and efficacy for age 80 or older patient with early primary high-risk NMSC. As a retrospective and monocentric report, we collected 80+ year-old patients with early primary high-risk non-melanoma skin cancer treated by personalized iodine-125 seeds interstitial brachytherapy (PISI-BT) between December 2003 and May 2020. Survival status, efficacy, adverse effects (AEs), cosmetic result, cost were recorded (data cut-off, November 20st 2021). Only 9 patients met the criteria, median age was 86 (81-90), 5 of 9 were Eastern Cooperative Oncology Group (ECOG) 1, and each of them suffered from at least one comorbidity. After a median follow-up of 29.3 months (3-99), only 2 patients alive, 6 patients showed complete response (CR), 3 showed partial response(PR), and stable disease(SD), progressive disease(PD) were 0, respectively. No recurrences, disease persistence and AEs were detected during the follow-up and the death causes was irrelevant to NMSC. The cosmetic result of Excellent and Good were 2 and 4, 3 cannot be evaluated. The cost (included in the scope of medical insurance reimbursement) was acceptable. PISI-BT could be an alternative in 80+ year-old patients with early primary high-risk NMSC." @default.
• W4386987688 created "2023-09-24" @default.
• W4386987688 creator A5032414197 @default.
• W4386987688 creator A5039655035 @default.
• W4386987688 creator A5051624923 @default.
• W4386987688 creator A5058337163 @default.
• W4386987688 date "2023-09-01" @default.
• W4386987688 modified "2023-10-18" @default.
• W4386987688 title "PO111" @default.
• W4386987688 doi "https://doi.org/10.1016/j.brachy.2023.06.212" @default.
• W4386987688 hasPublicationYear "2023" @default.
• W4386987688 type Work @default.
• W4386987688 citedByCount "0" @default.
• W4386987688 crossrefType "journal-article" @default.
• W4386987688 hasAuthorship W4386987688A5032414197 @default.
• W4386987688 hasAuthorship W4386987688A5039655035 @default.
• W4386987688 hasAuthorship W4386987688A5051624923 @default.
• W4386987688 hasAuthorship W4386987688A5058337163 @default.
• W4386987688 hasConcept C121608353 @default.
• W4386987688 hasConcept C126322002 @default.
• W4386987688 hasConcept C141071460 @default.
• W4386987688 hasConcept C16005928 @default.
• W4386987688 hasConcept C167135981 @default.
• W4386987688 hasConcept C197934379 @default.
• W4386987688 hasConcept C2777416452 @default.
• W4386987688 hasConcept C2777658100 @default.
• W4386987688 hasConcept C2777789703 @default.
• W4386987688 hasConcept C2778822529 @default.
• W4386987688 hasConcept C2779134260 @default.
• W4386987688 hasConcept C502942594 @default.
• W4386987688 hasConcept C509974204 @default.
• W4386987688 hasConcept C71924100 @default.
• W4386987688 hasConceptScore W4386987688C121608353 @default.
• W4386987688 hasConceptScore W4386987688C126322002 @default.
• W4386987688 hasConceptScore W4386987688C141071460 @default.
• W4386987688 hasConceptScore W4386987688C16005928 @default.
• W4386987688 hasConceptScore W4386987688C167135981 @default.
• W4386987688 hasConceptScore W4386987688C197934379 @default.
• W4386987688 hasConceptScore W4386987688C2777416452 @default.
• W4386987688 hasConceptScore W4386987688C2777658100 @default.
• W4386987688 hasConceptScore W4386987688C2777789703 @default.
• W4386987688 hasConceptScore W4386987688C2778822529 @default.
• W4386987688 hasConceptScore W4386987688C2779134260 @default.
• W4386987688 hasConceptScore W4386987688C502942594 @default.
• W4386987688 hasConceptScore W4386987688C509974204 @default.
• W4386987688 hasConceptScore W4386987688C71924100 @default.
• W4386987688 hasIssue "5" @default.
• W4386987688 hasLocation W43869876881 @default.
• W4386987688 hasOpenAccess W4386987688 @default.
• W4386987688 hasPrimaryLocation W43869876881 @default.
• W4386987688 hasRelatedWork W2002004870 @default.
• W4386987688 hasRelatedWork W2003938723 @default.
• W4386987688 hasRelatedWork W2047967234 @default.
• W4386987688 hasRelatedWork W2095272825 @default.
• W4386987688 hasRelatedWork W2118496982 @default.
• W4386987688 hasRelatedWork W2408887968 @default.
• W4386987688 hasRelatedWork W2424417377 @default.
• W4386987688 hasRelatedWork W2439875401 @default.
• W4386987688 hasRelatedWork W2525756941 @default.
• W4386987688 hasRelatedWork W4290320799 @default.
• W4386987688 hasVolume "22" @default.
• W4386987688 isParatext "false" @default.
• W4386987688 isRetracted "false" @default.
• W4386987688 workType "article" @default.